Skip to main content

Table 3 Dietary intakes among the study groups at baseline

From: Effect of lysine supplementation on hypertensive men and women in selected peri-urban community in Ghana

 

Lysine group1

Lysine group +1000 mg lysine2

Placebo group1

 

Mean

SD

% Risk of inadequacy3

mean

SD

% Risk of inadequacy3

Mean

SD

% Risk of inadequacy3

Men

n = 46

  

n = 46

  

n = 44

  

Total Energy kcal

1709

386

 

1709

386

 

1772

399

 

Total Protein g

51.35

14.51

 

51.35

14.51

 

53.37

13.35

 

Total N g

8.22

2.32

 

8.41

2.32

 

8.18

2.28

 

Utilizable Protein g 3

49.95

15.32

38.4

51.35

14.51

33.5

51.15

14.25

35.8

Lysine mg/kg/day 4

38.55

13.08

32.6

53.86

13.71

0

41.54

19.45

29.5

Sulfur Amino Acids mg/kg/day 4

23.49

6.93

10.9

23.49

6.93

10.9

24.74

9.22

11.4

Women

n = 44

  

n = 44

  

n = 41

  

Total Energy kcal

1406

483

 

1406

483

 

1435

335

 

Total Protein g

42.88

13.75

 

42.88

13.75

 

45.05

13.80

 

Total N g

6.86

2.2

 

7.05

2.20

 

6.98

2.25

 

Utilizable Protein g3

40.82

13.65

56.6

42.87

13.76

51.2

43.65

14.10

58.7

Lysine mg/kg/day 4

32.20

12.34

50

48.41

13.99

11.4

33.44

16.94

48.8

Sulfur Amino Acids mg/kg/day4

20.00

7.43

31.8

20.00

7.43

31.8

19.69

8.23

39.0

  1. No significant differences in the lysine and control groups before adding lysine tested using independent sample t-test
  2. The group reveals the expected enhancement in baseline value of the lysine group nutrients on adding 1000 mg of lysine which is corresponding to the quantity of supplement supplied
  3. Percent at risk of protein deficiency, based on a requirement of protein of 0.66 g/kg intended for adults (WHO, 2007)
  4. Adult amino acid requirements: 30 mg/kg/day lysine, 15 mg/kg/day sulfur amino acids, 15 mg/kg/day threonine, 4 mg/kg/day tryptophan (WHO, 2007)
  5. Difference from placebo group, p < 0.001